Search

In Stock

Buy Inrebic (fedratinib) Online

DISEASE INDICATIONS: Myelofibrosis

MANUFACTURER: Impact Biomedicines, Inc.

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Inrebic, known by its generic name Fedratinib, is a medication used to treat certain rare bone marrow disorders, specifically myelofibrosis.

$5,242.36

Clear
Compare

Inrebic, known by its generic name Fedratinib, is a medication used to treat certain rare bone marrow disorders, specifically myelofibrosis. Myelofibrosis is a type of myeloproliferative neoplasm (MPN) characterized by the overproduction of abnormal blood cells in the bone marrow, leading to symptoms such as fatigue, anemia, enlarged spleen, and potentially life-threatening complications. Here is a detailed description of Inrebic (Fedratinib):

  1. Mechanism of Action: Fedratinib is classified as a JAK2 (Janus kinase 2) inhibitor. It works by blocking the activity of the JAK2 enzyme, which plays a key role in the signaling pathways that lead to the overproduction of abnormal blood cells in myelofibrosis. By inhibiting JAK2, Fedratinib helps regulate blood cell production and reduce the symptoms associated with myelofibrosis.
  2. Indications: Inrebic is indicated for the treatment of adults with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis. It is intended for those who have symptomatic disease, including enlarged spleen and related symptoms.
  3. Administration: Fedratinib is taken orally in the form of capsules. The dosing regimen is typically determined by the prescribing physician and is based on the patient’s specific condition and response to treatment.
  4. Effectiveness: Clinical studies have shown that Inrebic can effectively reduce spleen size, improve symptoms, and enhance overall quality of life in patients with myelofibrosis. It may also help manage anemia and decrease the need for blood transfusions.
  5. Safety Profile: Like all medications, Fedratinib may have potential side effects, which can vary from person to person. Common side effects may include gastrointestinal symptoms, fatigue, dizziness, and low blood platelet counts. Patients should discuss potential side effects and any concerns with their healthcare providers.
  6. Monitoring: Patients prescribed Inrebic may require regular monitoring of their blood cell counts, liver function, and overall response to treatment. This helps ensure that the medication is effectively managing their myelofibrosis.
  7. Contraindications: Fedratinib is generally not recommended for individuals with known hypersensitivity to the drug or those with severe liver impairment.
  8. Research and Development: Inrebic represents a valuable treatment option for myelofibrosis, a condition that can significantly impact the quality of life for affected individuals. Ongoing research may explore its long-term safety and efficacy, as well as its potential use in other related disorders.

It is crucial for individuals with myelofibrosis to consult with a healthcare provider who is knowledgeable about this rare bone marrow disorder and its treatment options. Inrebic (Fedratinib) offers hope for symptom relief and improved well-being for those living with myelofibrosis.

Package

120 capsules of 100 mg

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Givlaari (givosiran) Online

(0 Reviews)
DISEASE INDICATIONS: Acute Hepatic Porphyria (AHP) MANUFACTURER: Alnylam Pharmaceuticals USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Givlaari, known by its generic name Givosiran, is a pharmaceutical medication used to treat a rare genetic disorder called acute hepatic porphyria (AHP). This innovative medication represents a significant advancement in the management of this condition, which is characterized by recurrent, severe attacks of abdominal pain, neurological symptoms, and potential life-threatening complications.

Buy Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo) Online

$24,063.64
(0 Reviews)
DISEASE INDICATIONS: Thromboembolism MANUFACTURER: Alexion Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Andexxa, with its generic name coagulation factor Xa (recombinant), inactivated-zhzo, is a specialized medication used in the field of hematology and coagulation medicine. It is primarily designed to address life-threatening bleeding events or complications associated with the use of certain anticoagulant medications, specifically direct or indirect factor Xa inhibitors.

Buy Ondexxya (andexanet alfa) Online

$16,421.35
(0 Reviews)
DISEASE INDICATIONS: Thromboembolism MANUFACTURER: Alexion Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Ondexxya, known by its generic name Andexanet Alfa, is a medication used as a reversal agent for certain anticoagulant medications. It is primarily used in emergency situations when rapid reversal of the anticoagulant effects is necessary, particularly in cases of life-threatening bleeding or when invasive procedures are required.

Buy Accrufer (ferric maltol) Online

(0 Reviews)
DISEASE INDICATIONS: Iron deficiency MANUFACTURER: Shield Therapeutics USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Swissmedic (CH) Accrufer, with the generic name ferric maltol, is a prescription medication used in the treatment of iron deficiency anemia in adults. It is classified as an iron replacement therapy and is designed to help raise and maintain healthy levels of iron in the body.

Buy Feraccru (ferric maltol) Online

$162.85
(0 Reviews)
DISEASE INDICATIONS: Iron deficiency MANUFACTURER: Shield Therapeutics USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Swissmedic (CH) Feraccru, known by its generic name Ferric Maltol, is a pharmaceutical medication used to treat iron deficiency anemia in adult patients with inflammatory bowel disease (IBD). It is a novel oral iron replacement therapy designed to help replenish iron levels in individuals who have difficulty absorbing iron through their gastrointestinal system.

Buy Adakveo (crizanlizumab) Online

$1,844.95
(0 Reviews)
DISEASE INDICATIONS: Sickle Cell Disease MANUFACTURER: Novartis USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Adakveo, with its active ingredient crizanlizumab, is a prescription medication used in the treatment of a specific medical condition known as sickle cell disease (SCD).

Buy Ultomiris (ravulizumab) Online

(0 Reviews)
MANUFACTURER: Alexion Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Pharmaceuticals and Medical Devices Agency (PMDA) Ultomiris, known by its generic name Ravulizumab, is a medication used to treat two rare and life-threatening blood disorders, namely paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).

Back to Top
Product has been added to your cart